---
ai_schema_version: 1
doc_id: FORGE-RESUME-CHECKPOINT-20261019
doc_kind: SNAPSHOT
doc_status: SNAPSHOT
authority_scope: NONE
source_ref: multiple
evidence_level: MIXED
last_reviewed: 2026-10-19
supersedes: none
---

# FORGE — Durable Pause / Resume Checkpoint

**Snapshot:** 2026-10-19 · **Status:** OWNER_PAUSED · **Purpose:** resume from repository facts, without relying on this chat or trusting a stale task list.

**One-line trigger:** `كمل آخر حاجة في FORGE`. A future agent must read the checkpoint and show a fresh status table plus dependency roadmap, then continue only with an **already-authorized** bounded item in `ACTIVE_PLAN.md`. If it needs approval, ask once and stop.

> This checkpoint is a historical handoff, **not** the executable queue, scientific authority, certification, permission to merge, or claim of readiness. Do not perform background work while paused.

## 1. Start here: five-file navigation

| File | Role | Governs execution? |
|---|---|---|
| `CLAUDE.md` | Repository and scientific working rules; automatic resume trigger | Repository rules only |
| `docs/work/ACTIVE_PLAN.md` | Active epic, bounded tasks, prerequisites, approval status | **YES — sole executable queue** |
| [Resume Dashboard](RESUME_DASHBOARD_2026_10_19.md) | Current-state table format, ★ priority rubric, roadmap | **NO — derived snapshot** |
| [Decision Register](RESUME_DECISION_REGISTER_2026_10_19.md) | Unresolved owner/scientific decisions, evidence and permission gates | **NO — recommendations only** |
| [Build vs Buy Handoff](BVB_RESUME_HANDOFF_2026_10_19.md) | All BVB phases, 97-component counts, FDA reconciliation, six report hashes, baseline policy | **NO — unapproved audit** |

Also read `docs/work/PROGRESS.md` for executed history, `docs/project/FORGE_MASTER_PLAN.md` for strategy, and `docs/discovery/FORGE_GENESIS.md` for Genesis semantics. Capability maturity, frozen core, performance and assurance contracts retain their original authority. In case of conflict, obey scope ownership and record a decision requirement; do not invent precedence.

## 2. Mission — what not to lose

**FORGE** is a **solver-neutral scientific reasoning and trust layer**, not a universal solver. External numerical providers compute. FORGE independently owns evidence admission, physical applicability, provenance, uncertainty, scientific refusal and verdicts, replay, falsification and sealed evaluation. LLM agents propose structured inputs but cannot decide scientific truth.

**Two long-term proof goals:** independently defensible **Blindfold Graduation** under honest strong equal-budget baselines; and an **independently reviewed narrow real engineering refusal/correction demonstration**. Neither is completed or certified by merely recording this snapshot.

## 3. Last observed Git/source state

Recorded via GitHub on 2026-10-19; **recheck before working**.

| Item | Historical fact / claim | What to recheck |
|---|---|---|
| Repo | `sharq-labs/forge` (private) | Correct linked repo and permission |
| Main | `a051af162647b20ab81bfbb99d0af0b533b32d11` at checkpoint creation | Fetch latest `main`; SHA here is intentionally historical |
| PR #169 | OPEN / not merged, P0+D1–D3 @ `abed661f`; no final OD-3 | Review, required checks and actual status |
| PR #170 | MERGED evidence-only, `2acf9da1` historical PR tip | See whether errata and review comments were closed |
| PR #171 | Draft documentation-resume PR created from `a051af1`; contains this snapshot | On return, check whether PR #171 landed or is still draft |
| Audited source | `abed661f`; **different from main's history** | All FDA paths and finding claims belong to exact audited tree |
| Windows worktree | `D:/forge-main-337519d1` previously shared by multiple agents | Verify real path, HEAD, branch, tracked/untracked/ignored files and active processes |

The FDA evidence is versioned in `docs/work/evidence/deep_audit_2026_10_19/` (merged PR #170). The registered audit describes **26 defects (6 MAJOR, 20 MINOR) and 8 observations**; four authorized runs R-03..R-06 reproduce **five findings**, on Windows Python 3.14.2, not the supported certification matrix. None of those facts alone proves current code repaired or certified.

## 4. The actual pause point

**Last clearly completed activities:** FDA evidence preservation via PR #170, BVB-0 inventory/reporting (97 components, **not implementation**), and Claude's read-only FDA-05/06 scientific scoring closure design + adversarial self-challenge as reported by the owner. Some full design files were still uncommitted locally, so their presence must be confirmed before any future work. PR #169 remains an independent integration obligation.

**Scientific issues that remain open at this snapshot:**
- FDA-05 vacuous-bracket scoring is reproduced on a pair, not a proven false end-to-end lift PASS. The later proposed F5-A has important flaws; the scientifically valid choice between F5-IS, revised F5-A and conservative F5-D is **UNRESOLVED**.
- FDA-06 cap is too narrow in a reproduced capping-function case; final family/applicability must distinguish expressive capability and observed equal-budget search competence. No full lift impact has been executed.
- O-1 Holm inputs are bootstrap fractions of resampled means, **not yet qualified p-values**. Final null/test must account for candidate cap, strongest-baseline selection, multiplicity and repeated submissions.
- B-LEAK is a previous formal benchmark **blocker** until independently isolated.
- FDA-01 replay/UQ authority (source-only), FDA-02 state clock (source-only), FDA-03 materials conflict (executed), FDA-04/14 MCP UQ (executed), BO4/BO9, D4 archive readback, OD-22..34/OD-29/OD-B1, required Linux OD-3 and various integration/prereg gates remain pending.
- PR #170 may need a **separate erratum** for inaccurate register `method` metadata, an integrity verifier that does not fail closed, and incomplete 20-field JSON claim. The historical SHA-pinned original must not be silently rewritten.
- Gmsh and transitive numerical provider licences need specific commercial distribution review.
- Numerical/engineering epic has numerous parallel Codex M1/semantic/checkpoint branches documented in `ACTIVE_PLAN.md`. Do not force these into the Genesis queue, claim their tests ran, or change their owners.

**BVB is included deliberately:** original KEEP 69 / AUDIT 21 / REPLACE 3 / DEFER 4; proposed FDA correction KEEP 67 / AUDIT 23 (unapproved). New optional baselines PySR, full-grammar and BoTorch require independent qualification and preregistration. Provider replacement is not an excuse to move Trust authority outside FORGE.

## 5. Uncommitted / local-only preservation risk

At pause, sessions reported the following `docs/work/` files in the Windows worktree **without GitHub visibility**:

- **BVB (six):** `BVB_40_ALGORITHM_INVENTORY.md`, `BVB_SCIENTIFIC_COMPARISON_MATRIX.md`, `BVB_LICENSE_AND_DEPENDENCY_AUDIT.md`, `BVB_NUMERICAL_EQUIVALENCE_PLAN.md`, `BVB_PRE_BLINDFOLD_ROADMAP.md`, `BVB_OWNER_DECISIONS.md`. The exact reported SHA-256 values are recorded in [BVB handoff](BVB_RESUME_HANDOFF_2026_10_19.md).
- **BVB addendum:** `BVB_FDA_RECONCILIATION_ADDENDUM.md`.
- **Genesis / scoring:** `FDA_05_SCORING_CLOSURE_DESIGN.md`, `FDA_06_CAP_SCOPE_CLOSURE_DESIGN.md`, `GENESIS_SCORING_STATISTICAL_DEPENDENCIES.md`, `OWNER_DECISION_PACKAGE.md`, `GENESIS_SCORING_DESIGN_CHALLENGE.md`, and `GENESIS_STEP0_A1_READINESS_REVIEW.md`.
- **D4:** `D4_ARCHIVE_COMPATIBILITY_DESIGN_REVIEW.md`.
- A copied FDA preservation package was also reported at `docs/work/evidence/fda_audit_2026_10_19/`; this may duplicate merged #170 and **must not be recommitted blindly**.

These are **last reported names**, not a guarantee of availability, freshness or independent truth. Read-only inventory, hash verification and concurrency review first. Do not reset, stash, clean, rewrite, copy unchecked or delete untracked/ignored material. A future durable-preservation PR needs separate owner instruction and secret/benchmark-answer review.

## 6. Resume algorithm — exactly this order

1. **Verify** repository, HEADs, PR states, local worktree cleanliness/concurrency, active epic and required contracts. If inaccessible, write **UNVERIFIED**; do not assume.
2. **Render** a status table covering Trust/PRs, FDA-05/06, O-1, B-LEAK, BVB, baseline arms, v0.3, engineering demo and numerical epic, with `evidence SHA | status | ★ priority | dependency | next action`. Use fresh data, not copied statuses.
3. **Render** a compact updated dependency roadmap from [dashboard](RESUME_DASHBOARD_2026_10_19.md).
4. **Distinguish** last completed action, first unfinished action in `ACTIVE_PLAN.md`, blockers, authorizations, and one proposed next bounded step.
5. **Continue** that step only when already authorized. If it requires scientific design approval, tests, installs, code change, push/merge, OD-3 or formal measurement, ask for **one** explicit decision and stop.
6. **Preserve** historical SHA-pinned evidence. Record actual executed command/results in `PROGRESS.md` when applicable; update live plan/checkpoint only under suitable owner authority.

For **"الجدول"**, **"وصلنا لفين"**, **"قيّم"**: report table + roadmap only. For **"كمل آخر حاجة"**: report first, then bounded authorized work. Reply in Egyptian Arabic with exact English technical names and ★ relative *attention*, never invented pass/speedup/maturity.

## 7. Business context (not a scientific gate)

An earlier conversational **hypothetical** IP-asset-sale range was **USD 100k–500k**, with illustrative midpoint USD 250k. This is **not** a certified valuation, buyer bid, enterprise valuation, sale price, or evidence of revenue; don't multiply it into scientific readiness. Any actual pricing requires IP/licensing due diligence, demonstrated customer value, commercial references and transaction comparisons.

## 8. Owner's short command

```text
كمل آخر حاجة في FORGE. راجع CLAUDE.md وACTIVE_PLAN.md وملف الاستئناف والـDashboard وBVB Handoff، اتحقق من حالة GitHub والـworktree، اعرض جدول الحالة بالأولويات والاعتماديات وارسم الخريطة، وبعدين كمل أول خطوة عندها تصريح بالفعل. ما تعملش Merge أو اختبار ثقيل من غير موافقتي.
```

**Stop point:** OWNER_PAUSED. No automatic execution while waiting.
